Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Sana Biotechnology, Inc. (SANA). Financial results for the fourth quarter of 2020.

25.03.2021

GAAP net loss - $7.4 per share. 
Cash and cash equivalents and marketable securities- $412 million.